[Cyclocryotherapy in the treatment of glaucoma].
33 patients (37 eyes) of neovascular and non-neovascular glaucoma were treated with cyclocryotherapy and followed up for 3-67 months, averaging 25 months. The IOP was brought under 2.73 kPa (21 mmHg) in 57.1% of the neovascular and 33.3% of the non-neovascular glaucomatous eyes, with an overall average IOP drop of 3.07 kPa (23.1 mmHg). Pain was controlled in 86.7% of the eyes. Cyclocryotherapy appeared to be an effective procedure for cases of refractory glaucoma, particularly those of neovascular origin. The complications and their mechanism were also discussed.
Li
J Z
JZ
Department of Ophthalmology, Peking Union Medical College Hospital, Beijing.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002924:Ciliary Body / Q000601:surgery*; D003452:Cryosurgery / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005901:Glaucoma / Q000601:surgery*; D015355:Glaucoma, Neovascular / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000209:etiology; D014605:Uveitis / Q000209:etiology